FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic rosuvastatin calcium product from Quallent Pharmaceuticals Health LLC under ANDA208898.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)